Label
Description
Erlotinib indication Non-Small Cell Lung Carcinoma
A Knowledge Graph Assertion from IDG
Nintedanib indication Non-Small Cell Lung Carcinoma
(1R)-6-Fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(1-methylethyl)-3-pyridinyl]-4-[(2S)-2-methyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl]-pyrido[2,3-d]-pyrimidin-2(1H)-one indication Non-Small Cell Lung Carcinoma
BLU-667 indication Non-Small Cell Lung Carcinoma
Vinorelbine indication Non-Small Cell Lung Carcinoma
3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile indication Non-Small Cell Lung Carcinoma
Hematoporphyrin indication Non-Small Cell Lung Carcinoma
Brigatinib indication Non-Small Cell Lung Carcinoma
Icotinib indication Non-Small Cell Lung Carcinoma
Paclitaxel indication Non-Small Cell Lung Carcinoma